切换至 "中华医学电子期刊资源库"
高级检索
中华妇幼临床医学杂志(电子版)

中华妇幼临床医学杂志(电子版) ›› 2019, Vol. 15 ›› Issue (03) : 292 -299. doi: 10.3877/cma.j.issn.1673-5250.2019.03.009

所属专题： 文献；

论著

尿源性脓毒症患儿的临床特点分析
陈丽妮1, 罗黎力2, 李德渊2, 刘忠强2, 乔莉娜2,†()   
  1. 1. 四川大学华西第二医院儿童重症监护室、出生缺陷与相关妇儿疾病教育部重点实验室，成都　610041；四川大学华西临床医学院，成都　610041
    2. 四川大学华西第二医院儿童重症监护室、出生缺陷与相关妇儿疾病教育部重点实验室，成都　610041
  • 收稿日期:2019-01-08 修回日期:2019-04-19 出版日期:2019-06-01
  • 通信作者: 乔莉娜

Clinical characteristics of children with urosepsis

Lini Chen1, Lili Luo2, Deyuan Li2, Zhongqiang Liu2, Lina Qiao2,†()   

  1. 1. Pediatric Intensive Care Unit, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China; West China School of Medicine, Sichuan University, Chengdu 610041, Sichuan Province, China
    2. Pediatric Intensive Care Unit, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
  • Received:2019-01-08 Revised:2019-04-19 Published:2019-06-01
  • Corresponding author: Lina Qiao
  • About author:
    Corresponding author: Qiao Lina, Email:
  • Supported by:
    Project of Sichuan Academic and Technology Leadership Training Support((2017) 919-23); Sichuan Science and Technology Plan Project(2019YFS0245)
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

陈丽妮, 罗黎力, 李德渊, 刘忠强, 乔莉娜. 尿源性脓毒症患儿的临床特点分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2019, 15(03): 292-299.

Lini Chen, Lili Luo, Deyuan Li, Zhongqiang Liu, Lina Qiao. Clinical characteristics of children with urosepsis[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2019, 15(03): 292-299.

目的

探讨尿源性脓毒症患儿的临床特点。

方法

选择2017年1月至2018年6月，在四川大学华西第二医院住院治疗的51例尿源性脓毒症患儿为研究对象，并纳入研究组。按照1∶2的比例，采用Microsoft Excel 2016随机抽取功能，抽取同期在本院住院治疗的102例非尿源性脓毒症患儿纳入对照组。收集2组患儿的一般临床资料、实验室检查指标、脏器功能损害及预后情况。采用独立样本t检验，对2组患儿的血小板计数(PLT)、纤维蛋白原(Fib)和红细胞沉降率(ESR)等进行统计学分析。采用Mann-Whitney U秩和检验，对2组患儿的白细胞计数(WBC)、血红蛋白(Hb)、丙氨酸转移酶(ALT)、天冬氨酸氨基转移酶(AST)、白蛋白、总胆红素(TB)、乳酸脱氢酶(LDH)、肌酐、血尿素氮(BUN)、血糖、D-二聚体(DDI)、纤维蛋白原降解物(FDP)、N端脑钠肽(NTBNP)、肌钙蛋白I (cTnI)、血清pH值与乳酸，以及血清Na＋、K＋、Ca2＋及Cl－等进行统计分析。采用χ2检验或者连续性校正χ2检验，对2组患儿的性别构成比、儿科重症监护病房(PICU)转入率、病死率等计数资料进行统计分析。本研究遵循的程序符合2013年修订的《世界医学协会赫尔辛基宣言》要求。2组患儿性别构成比比较，差异无统计学意义(P>0.05)。

结果

①研究组患儿中位年龄为6个月(4～12个月)，小于对照组的10个月(5～24个月)，差异有统计学意义(Z＝－2.660，P＝0.008)。②研究组患儿的WBC及CRP水平分别为17.4×109/L[(11.8～26.6)×109/L]和120 mg/L(87～160 mg/L)，均明显高于对照组的12.0×109/L[(5.0～17.6)×109/L]和48 mg/L(20～135 mg/L)，2组比较，差异均有统计学意义(Z＝－4.145、－4.465，P均<0.001)。研究组患儿WBC>15×109/L及CRP>40 mg/L所占比例，分别为62.7%(32/51)和90.2%(46/51)，均高于对照组的38.2%(39/102)和55.9%(57/102)，组间比较，差异均有统计学意义(χ2＝8.212、18.197，P＝0.004、<0.001)。③研究组患儿的PLT、血清Ca2＋、Fib和pH值分别为(344.1±148.7)×109/L，2.36 mmol/L (2.29～2.49 mmol/L)，(492.0±185.1)mg/dL和7.4(7.4～7.5)，均高于对照组的(271.2±147.5)×109/L，2.21 mmol/L (0.08～2.39 mmol/L)，(346.0±165.8)mg/dL和7.4(7.3～7.4)，组间比较，差异均有统计学意义(t＝—2.871，P＝0.005；Z＝－4.002，P＝0.992；t＝－3.639，P<0.001；Z＝－2.108，P＝0.035)。研究组患儿的AST、LDH、DDI和cTnI水平分别为35.0 U/L(25.8～44.2 U/L)，534.5 U/L(471.5～649.5 U/L)，1.1 mg/L(0.5～2.2 mg/L)，0.01 μg/L(0.01～0.01 μg/L)，均低于对照组的46.5 U/L(46.0～87.2 U/L)，673.0 U/L(535.0～1 106.0 U/L)，2.5 mg/L(1.2～4.0 mg/L)和0.01 μg/L(0.01～0.04 μg/L)，组间比较，差异均有统计学意义(Z＝－4.130、3.851、－2.175、－3.716，P均<0.05)。④研究组患儿中，需要呼吸支持治疗、动脉血氧分压(PaO2)/吸入氧气分数(FiO2)<300 mmHg、部分凝血活酶时间(APTT)延长>10 s、PLT<150×109/L、cTnI升高、AST>100 U/L、有神经系统症状者、血清Ca2＋<2.1 mmol/L所占比例，分别为11.8%(6/51)、3.9%(2/51)、8.0%(2/25)、7.8%(4/51)、3.7%(1/27)、6.0%(3/50)、29.4%(15/51)、6.1%(3/49)，均低于对照组的47.1%(48/102)、27.5%(28/102)、35.3%(24/68)、20.6%(21/102)、34.4%(22/64)、25.5%(26/102)、61.8(63/102)和27.6%(27/98)，2组比较，差异均有统计学意义(χ2＝18.545、11.941、6.761、4.040、9.458、8.255、14.241、9.235，P均<0.05)。⑤研究组51例患儿中，49例(96.1%，49/51)尿常规检查结果可见不同数量白细胞及脓细胞，另外2例患儿多次尿常规及尿培养试验均无异常，但是腹部CT检查结果提示肾脓肿。⑥研究组患儿PICU转入率和病死率，均显著低于对照组，并且差异均有统计学意义(χ2＝17.480、6.142，P均<0.05)。

结论

尿源性脓毒症患儿常伴明显白细胞及CRP升高，脏器功能损害较轻，总体预后较好。对伴有明显炎症指标升高，而脏器损害较轻的尿源性脓毒症患儿，可完善清洁中段小便分析，必要时进行尿培养试验及泌尿道超声、CT等检查，对确定感染源有重大意义。

关键词: 脓毒症, 泌尿道感染, 炎症, 细菌感染, 降钙素原, 诊断, 预后, 儿童
Objective

To discuss clinical characteristics of children with urosepsis.

Methods

Between January 2017 and June 2018, a total of 51 children were admitted as study group with the diagnosis of urosepsis. And another 102 children with non-urosepsis were selected into control group through random extraction function of Microsoft Excel 2016. The medical records of demographic data, laboratory tests, and prognosis were collected. Independent-samples t test was performed on platelet count (PLT), fibrinogen (Fib), and erythrocyte sedimentation rate (ESR). White blood cell (WBC), hemoglobin (Hb), alanine transferase (ALT), aspartate aminotransferase (AST), albumin, total bilirubin (TB), lactate dehydrogenase (LDH), creatinine, blood urea nitrogen (BUN), serum Na+ , serum K+ , serum Ca2+ , serum Cl-, glucose, D-dimer (DDI), fibrinogen degradation (FDP), N-terminal pro-brain natriuretic peptide (NTBNP), troponin I (cTnI), pH value, and lactic acid were compared by Mann-Whitney U rank sum test. The chi-square test or continuity correction were used to perform statistical analysis on the ratios of gender ratio, pediatric intensive care unit (PICU) occupancy rate, and mortality. This study was in line with the World Medical Association Declaration of Helsinki revised in 2013. There was no significant difference in gender composition ratio between two groups (χ2=1.593, P=0.207).

Results

①The median age of study group was 6-month old (4-12 months old), which was younger than that of control group [10-month old (5-24 months old)] (Z=-2.660, P=0.008). ② The levels of WBC and CRP in study group were 17.4×109/L [(11.8-26.6)×109/L] and 120 mg/L (87-160 mg/L), which were higher than 12.0×109/L [(5.0-17.6)×109/L] and 48 mg/L (20-135 mg/L) in control group. The differences between two groups were statistically significant (Z=-4.145, -4.465; P all<0.001). The proportion of WBC>15×109/L and CRP>40 mg/L in study group were 62.7% (32/51) and 90.2%(46/51), which were higher than those of control group 38.2%(39/102) and 55.9%(57/102), and the differences between two groups were statistically significant (χ2=8.212, 18.197; P=0.004, <0.001). ③ The values of PLT, Ca2+ , Fib and pH value in study group were (344.1±148.7)×109/L, 2.36 mmol/L (2.29-2.49 mmol/L), (492.0±185.1) mg/dL and 7.4 (7.4-7.5), which were higher than (271.2±147.5)×109/L, 2.21 mmol/L (0.08-2.39 mmol/L), (346.0±165.8) mg/dL and 7.4(7.3-7.4) of control group, and the differences between two groups were statistically significant (t=-2.871, P=0.005; Z=-4.002, P=0.992; t=-3.639, P<0.001; Z=-2.108, P=0.035). While the levels of AST, LDH, DDI and cTnI of study group were 35.0 U/L (25.8-44.2 U/L), 534.5 U/L (471.5-649.5 U/L), 1.1 mg/L (0.5-2.2 mg/L), 0.01 μg/L (0.01-0.01 μg/L), which were lower than 46.5 U/L (46.0-87.2 U/L), 673.0 U/L (535.0-1 106.0 U/L), 2.5 mg/L(1.2-4.0 mg/L) and 0.01 μg/L (0.01-0.04 μg/L) of control group, and the differences between two groups were statistically significant (Z=-4.130, 3.851, -2.175, -3.716; P all<0.05). ④The proportion of children required respiratory support, partial pressure of oxygen in artery(PaO2)/fraction of inspired oxygen(FiO2)<300 mmHg, activated partial thromboplastin time(APTT) prolongation >10 s, PLT<150×109/L, elevated in cTnI, AST>100 U/L, neurological symptoms, Ca2+ <2.1 mmol/L in study group were 11.8% (6/51), 3.9% (2/51), 8.0% (2/25), 7.8% (4/51), 3.7% (1/27), 6.0% (3/50), 29.4% (15/51), 6.1% (3/49), lower than 47.1%(48/102), 27.5%(28/102), 35.3% (24/68), 20.6% (21/102), 34.4% (22/64), 25.5% (26/102), 61.8% (63/102) and 27.6%(27/98) of control group, and the differences were statistically significant (χ2=18.545, 11.941, 6.761, 4.040, 9.458, 8.255, 14.241, 9.235; P all<0.05). ⑤ Among 51 children in study group, 49 children (96.1%, 49/51) showed increased levels of leucocytes and pus cells according to urine routine examination results, another 2 children showed normalities in urine and urine culture but abdominal CT examination results showed renal abscess. ⑥ The PICU transfer rate and mortality of study group were significantly lower than those of control group, and the differences between two groups were statistically significant (χ2=17.480, 6.142; P all<0.05).

Conclusions

Children with urosepsis is more likely to have higher WBC and CRP level, lower organ function rate and better prognosis. For children with sepsis accompanied by high level of inflammatory maker and lower organ dysfunction rate, it is of great significance to carry out early urinalysis, urine culture and have ultrasound or CT of urinary system.

Key words: Sepsis, Urinary tract infections, Inflammasomes, Bacterial infections, Procalcitonin, Diagnosis, Prognosis, Child
表1 2组患儿炎症指标比较
组别 例数 WBC[×109/L，M(P25～P75)] 中性粒细胞百分比(%，±s) CRP[mg/L，M(P25～P75)] PCT[ng/mL，M(P25～P75)]
研究组 51 17.4(11.8～26.6) 61.2±15.8 120(87～160) 6.8(2.0～22.1)a
对照组 102 12.0(5.0～17.6) 58.7±20.5 48(20～135) 4.2(0.6～17.1)a
检验值 ? Z＝－4.145 t＝－0.806 Z＝－4.465 Z＝－1.449
P值 ? <0.001 0.422 <0.001 0.147
组别 例数 WBC>15×109/L[例数(%)] 中性粒细胞百分比>80%[例数(%)] CRP>40 mg/L[例数(%)] PCT>0.5 ng/mL[例数(%)]
研究组 51 32(62.7) 4(7.8) 46(90.2) 34(94.4)a
对照组 102 39(38.2) 19(18.6) 57(55.9) 64(84.2)a
检验值 ? χ2＝8.212 χ2＝3.096 χ2＝18.197 χ2＝1.497
P值 ? 0.004 0.078 <0.001 0.221
表2 2组患儿降钙素原不同升高程度比较
组别 例数 PCT值升高程度[例数(%)]
0～5 ng/mL 5～10 ng/mL 10～15 ng/mL 15～20 ng/mL >20 ng/mL
研究组 36 13(36.1) 8(22.2) 3(8.3) 0(0) 12(33.3)
对照组 76 42(55.3) 10(13.2) 3(3.9) 5(6.6) 16(21.1)
χ2值 ? 7.614
P值 ? 0.087
表3 2组患儿实验室检查结果比较
组别 例数 肝功能
ALT [U/L，M(P25～P75)] AST [ U/L，M(P25～P75)] 白蛋白[g/L，M(P25～P75)] TB [μmol/L，M(P25～P75)] LDH [U/L，M(P25～P75)]
研究组 51 34.0(27.0～44.0) 35.0(25.8～44.2) 37.1(32.2～39.1) 4.1(2.1～7.3) 534.5(471.5～649.5)
对照组 102 36.5(25.0～54.2) 46.5(46.0～87.2) 36.9(31.2～40.9) 4.6(2.3～9.4) 673.0(535.0～1 106.0)
检验值 ? Z＝－1.104 Z＝－4.130 Z＝－0.118 Z＝－0.635 Z＝－3.851
P值 ? 0.269 <0.001 0.906 0.525 <0.001
组别 例数 血常规检查 肾功能
Hb(g/L，±s) PLT(×109/L，±s) 肌酐[μmol/L，M(P25～P75)] BUN [mmol/L，M(P25～P75)])
研究组 51 101.0(89.0～109.0) 344.1±148.7 31.0(26.0～36.5) 3.2(2.2～4.2)
对照组 102 104.5(88.5～115.0) 271.2±147.5 31.5(25.0～40.0) 2.8(2.3～4.3)
检验值 ? Z＝0.681 t＝－2.871 Z＝－0.370 Z＝－0.209
P值 ? 0.497 0.005 0.711 0.835
组别 例数 血糖[mmol/L，M(P25～P75)] 电解质检查
血Na＋ [mmol/L，M(P25～P75)] 血K＋[mmol/L，M(P25～P75)] 血Cl－[mmol/L，M(P25～P75)] 血Ca2＋[mmol/L，M(P25～P75)]
研究组 51 5.5(4.9～6.1) 135.2(133.8～137.8) 4.2(3.7～4.6) 102.9(100.2～105.0) 2.3(2.3～2.5)
对照组 102 5.6(4.9～6.4) 136.0(132.3～138.0) 4.2(3.7～4.5) 102.6(97.9～107.0) 2.2(0.1～2.4)
检验值 ? Z＝－0.601 Z＝－0.266 Z＝－0.452 Z＝－0.010 Z＝－4.002
P值 ? 0.548 0.790 0.652 0.992 <0.001
组别 例数 ESR(mm/h，±s) 凝血功能
Fib(mg/dL，±s) DDI [mg/L，M(P25～P75)] FDP [μg/mL，M(P25～P75)]
研究组 51 48.8±36.4 492.0±185.1 1.1(0.5～2.2) 5.7(3.6～11.6)
对照组 102 42.2±30.0 346.0±165.8 2.5(1.2～4.0) 9.2(4.5～13.7)
检验值 ? t＝－0.608 t＝－3.639 Z＝－2.175 Z＝－0.931
P值 ? 0.547 <0.001 0.030 0.352
组别 例数 NTBNP [pg/mL，M(P25～P75)] cTnI [μg/L，M(P25～P75)] pH值[M(P25～P75)] 乳酸[mmol/L，M(P25～P75)]
研究组 51 1 120.0(373.0～3 180.0) 0.01(0.01～0.01) 7.4(7.4～7.5) 1.8(1.3～2.4)
对照组 102 2 120.0(377.0～7 690.0) 0.01(0.01～0.04) 7.4(7.3～7.4) 1.8(1.1～2.6)
检验值 ? Z＝－1.133 Z＝－3.716 Z＝－2.108 Z＝－0.194
P值 ? 0.257 <0.001 0.035 0.846
表4 2组判断患儿脏器功能损害情况指标的发生率比较[%(n/n′)]
组别 例数 呼吸系统 凝血功能
呼吸支持治疗 PaO2/FiO2<300 mmHg PT延长>3 s APTT延长>10 s Fib<200 mg/L INR>1.5 PLT<150×109/L PLT<100×109/L
研究组 51 11.8(6/51) 3.9(2/51) 4.0(1/25) 8.0(2/25) 12.0(3/25) 4.0(1/25) 7.8(4/51) 3.9(2/51)
对照组 102 47.1(48/102) 27.5(28/102) 19.1(13/68) 35.3(24/68) 22.4(15/67) 13.2(9/68) 20.6(21/102) 13.7(14/102)
χ2值 ? 18.545 11.941 2.192 a 6.761 0.676 a 0.805 a 4.040 3.490
P值 ? <0.001 0.001 0.139 0.009 0.441 0.370 0.044 0.062
组别 例数 心血管系统 消化系统
低血压或者低灌注表现 乳酸>2.5 mmol/L cTnI升高 NTBNP>450 pg/mL 肠鸣音减弱或者消失 AST>100 U/L ALT>80 U/L TB>70 μmol/L
研究组 51 9.8(5/51) 14.3(2/14) 3.7(1/27) 63.6(7/11) 2.0(1/51) 6.0(3/50) 6.0(3/50) 2.0(1/50)
对照组 102 13.7(14/102) 25.0(15/60) 34.4(22/64) 74.5(38/51) 4.9(5/102) 25.5(26/102) 13.7(14/102) 4.9(5/102)
χ2值 ? 0.481 0.255 a 9.458 0.130 —0.195 a 8.255 2.016 －0.176 a
P值 ? 0.448 0.613 0.002 0.718 0.659 0.004 0.156 0.664
组别 例数 神经系统症状b 泌尿系统 电解质
BUN>82 mmol/L 肌酐>10.7 μmol/L 少尿或者无尿 血清Na＋<135 mmol/L 血清K＋<3.5 mmol/L 血K＋>5.5 mmol/L 血清Ca2＋<2.1 mmol/L
研究组 51 29.4(15/51) 4.1(2/49) 4.1(2/49) 3.9(2/51) 38.8(19/49) 18.4(9/49) 4.1(2/49) 6.1(3/49)
对照组 102 61.8(63/102) 4.9(5/102) 4.9(5/102) 2.9(3/102) 47.1(48/102) 20.6(21/102) 4.9(5/102) 27.6(27/98)
χ2值 ? 14.241 0.000 a 0.000 a 0.000 a 0.615 0.103 0.000 a 9.235
P值 ? <0.001 1.000 1.000 1.000 0.443 0.749 1.000 0.002
表5 2组患儿PICU转入率和病死率比较[例数(%)]
组别 例数 转入PICU 死亡
研究组 51 9(17.6) 0(0)
对照组 102 54(52.9) 14(13.7)
χ2值 ? 17.480 6.142
P值 ? <0.001 0.013
[1]
中华医学会儿科学分会急救学组. 儿童脓毒性休克(感染性休克)诊治专家共识(2015版)[J]. 中华儿科杂志，2015, 22(8): 739-743.
[2]
Stein R, Dogan HS, Hoebeke P, et al. Urinary tract infections in children: EAU/ESPU guidelines [J]. Eur Urol, 2015, 67(3): 546-558.
[3]
Hartman ME, Linde-Zwirble WT, Angus DC, et al. Trends in the epidemiology of pediatric severe sepsis [J]. Pediatr Crit Care Med, 2013, 14(7): 686-693.
[4]
Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016 [J]. Intensive Care Med, 2017, 43(3): 304-377.
[5]
Plunkett A, Tong J. Sepsis in children [J]. BMJ, 2015, 350: h3017.
[6]
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) [J]. JAMA, 2016, 315(8): 801-810.
[7]
Memar MY, Varshochi M, Shokouhi B, et al. Procalcitonin: the marker of pediatric bacterial infection [J]. Biomed Pharmacother, 2017, 96: 936-943.
[8]
Hosokawa Y, Shimizu T, Owari T, et al. Clinical evaluation of urosepsis in tane general hospital; clinical utility of measurement of procalcitonin [J]. Hinyokika Kiyo, 2017, 63(7): 259-262.
[9]
Pontrelli G, De Crescenzo F, Buzzetti R, et al. Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome: a Meta-analysis [J]. BMC Infect Dis, 2017, 17(1): 302.
[10]
Luaces-Cubells C, Mintegi S, Garcia-Garcia JJ, et al. Procalcitonin to detect invasive bacterial infection in non-toxic-appearing infants with fever without apparent source in the emergency department [J]. Pediatr Infect Dis J, 2012, 31(6): 645-647.
[11]
Kopczynska M, Sharif B, Cleaver S, et al. Red-flag sepsis and SOFA identifies different patient population at risk of sepsis-related deaths on the general ward [J]. Medicine (Baltimore), 2018, 97(49): e13238.
[12]
Buonaiuto VA, Marquez I, De Toro I, et al. Clinical and epidemiological features and prognosis of complicated pyelonephritis: a prospective observational single hospital-based study[J]. BMC Infect Dis, 2014, 14: 639.
[13]
Wagenlehner FME, Pilatz A, Weidner W, et al. Urosepsis: overview of the diagnostic and treatment challenges [J]. Microbiol Spectr, 2015, 3(5): 1-18.
[14]
Alkhenizan A, Elabd K. Non-therapeutic infant male circumcision. Evidence, ethics, and international law perspectives[J]. Saudi Med J, 2016, 37(9): 941-947.
[15]
Lo DS, Rodrigues L, Koch VHK, et al. Clinical and laboratory features of urinary tract infections in young infants [J]. J Bras Nefrol, 2018, 40(1): 66-72.
[16]
Shaikh N, Hoberman A, Hum SW, et al. Development and validation of a calculator for estimating the probability of urinary tract infection in young febrile children [J]. JAMA Pediatr, 2018, 172(6): 550-556.
[17]
Tzimenatos L, Mahajan P, Dayan PS, et al. Accuracy of the urinalysis for urinary tract infections in febrile infants 60 days and younger [J]. Pediatrics, 2018, 141(2): pii: e20173068.
[18]
Oreskovic NM, Sembrano EU. Repeat urine cultures in children who are admitted with urinary tract infections [J]. Pediatrics, 2007, 119(2): e325-e329.
[19]
Mariappan P, Loong CW. Midstream urine culture and sensitivity test is a poor predictor of infected urine proximal to the obstructing ureteral stone or infected stones: a prospective clinical study [J]. J Urol, 2004, 171(6 Pt 1): 2142-2145.
[20]
Dreger NM, Degener S, Ahmad-Nejad P, et al. Urosepsis--etiology, diagnosis, and treatment [J]. Dtsch Arztebl Int, 2015, 112(49): 837-847; quiz 848.
[21]
Wagenlehner FM, Tandogdu Z, Bjerklund Johansen TE. An update on classification and management of urosepsis [J]. Curr Opin Urol, 2017, 27(2): 133-137.
[22]
Zieger B. Imaging in urinary tract infections in childhood [J]. Radiologe, 2016, 56(11): 997-1012.
[23]
郭妍南，明华，陈秀英，等. 枸橼酸钠抗凝在脓毒症伴急性肾损伤患儿连续性静脉-静脉血液滤过治疗中的应用 [J/CD] . 中华妇幼临床医学杂志(电子版)，2016，12(6): 726-730.
[24]
Nelson CP, Johnson EK, Logvinenko T, et al. Ultrasound as a screening test for genitourinary anomalies in children with UTI [J]. Pediatrics, 2014, 133(3): e394-e403.
[25]
封志纯，余帮. 脓毒症遗传易感性的研究现状与进展[J/CD]. 发育医学电子杂志，2016，4(4)：247-252.
[1] 王亚红, 蔡胜, 葛志通, 杨筱, 李建初. 颅骨骨膜窦的超声表现一例[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(11): 1089-1091.
[2] 陶宏宇, 叶菁菁, 俞劲, 杨秀珍, 钱晶晶, 徐彬, 徐玮泽, 舒强. 右心声学造影在儿童右向左分流相关疾病中的评估价值[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(10): 959-965.
[3] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[4] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[5] 张洁, 罗小霞, 余鸿. 系统性免疫炎症指数对急性胰腺炎患者并发器官功能损伤的预测价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 68-71.
[6] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[7] 熊鹰, 林敬莱, 白奇, 郭剑明, 王烁. 肾癌自动化病理诊断：AI离临床还有多远？[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 535-540.
[8] 李伟, 宋子健, 赖衍成, 周睿, 吴涵, 邓龙昕, 陈锐. 人工智能应用于前列腺癌患者预后预测的研究现状及展望[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 541-546.
[9] 赵月, 田坤, 张宗明, 郭震天, 刘立民, 张翀, 刘卓. 降钙素原对老年急性重度胆囊炎发生的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 801-806.
[10] 王湛, 李文坤, 杨奕, 徐芳, 周敏思, 苏珈仪, 王亚丹, 吴静. 炎症指标在早发性结直肠肿瘤中的应用[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 802-810.
[11] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
[12] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[13] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[14] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[15] 陈慧, 邹祖鹏, 周田田, 张艺丹, 张海萍. 皮肤镜对头皮红斑性皮肤病辅助鉴别诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 692-698.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号